Literature DB >> 4299120

Antiviral agent from lambda-infected Escherichia coli K-12. I. Isolation.

Y M Centifanto.   

Abstract

Phagicin, which is an antiviral agent active against deoxyribonucleic acid (DNA) viruses such as vaccinia and herpes simplex, has been identified as a phage internal protein. It was found in infected Escherichia coli lysates, but could also be obtained by disruption of the purified infective particles after incubation with LiCl at 46 C for 15 min or by sonic treatment. After centrifugation at high speed, the antiviral activity was found in the DNA phase and could be separated by chromatography on Sephadex gels with 0.2 M phosphate buffer (pH 7.5) as the eluent. Phagicin present in lysates after removal of infective particles was nondialyzable and was bound to nucleic acids. It could be released during precipitation of nucleic acids by streptomycin sulfate, and in this form it could be easily dialyzed. The antiviral activity of phagicin was specific for herpes simplex and vaccinia viruses.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4299120      PMCID: PMC547537          DOI: 10.1128/am.16.6.827-834.1968

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  8 in total

1.  Thymineless induction in Escherichia coli K12 (lambda).

Authors:  D KORN; A WEISSBACH
Journal:  Biochim Biophys Acta       Date:  1962-11-26

2.  The transformation of Escherichia coli with deoxyribonucleic acid isolated from bacteriophage lambda-dg.

Authors:  A D KAISER; D S HOGNESS
Journal:  J Mol Biol       Date:  1960-12       Impact factor: 5.469

3.  An internal protein in T2 and T4 bacteriophages.

Authors:  L LEVINE; J L BARLOW; H VAN VUNAKIS
Journal:  Virology       Date:  1958-12       Impact factor: 3.616

4.  IDU therapy of herpes simplex.

Authors:  H E KAUFMAN; A B NESBURN; E D MALONEY
Journal:  Arch Ophthalmol       Date:  1962-05

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Purification and some possible functions of internal proteins from coliphage T2.

Authors:  U Bachrach; A Friedmann
Journal:  Biochem Biophys Res Commun       Date:  1967-03-09       Impact factor: 3.575

7.  A procedure for the extraction of DNA and protein ghosts from bacteriophage lambda.

Authors:  R D Dyson
Journal:  Biochem Biophys Res Commun       Date:  1966-01-04       Impact factor: 3.575

8.  Inhibition of Sindbis virus plaque formation by extracts of Escherichia coli.

Authors:  J Vilcek; J H Freer
Journal:  J Bacteriol       Date:  1966-12       Impact factor: 3.490

  8 in total
  5 in total

1.  Characterization of Escherichia coli bacterial viruses in commercial sera,.

Authors:  M R Geier; A F Attallah; C R Merril
Journal:  In Vitro       Date:  1975 Jan-Feb

2.  Lack of specific inhibition of Vaccinia plaque formation by bacteriophage lambda products.

Authors:  A Brown; S N Cohen
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

Review 3.  Possible Role for Bacteriophages in the Treatment of SARS-CoV-2 Infection.

Authors:  Vijaya Nath Mishra; Nidhi Kumari; Abhishek Pathak; Rajnish Kumar Chaturvedi; Arun Kumar Gupta; Rameshwar Nath Chaurasia
Journal:  Int J Microbiol       Date:  2020-09-19

Review 4.  Phage therapeutics: from promises to practices and prospectives.

Authors:  Kanika Bhargava; Gopal Nath; Amit Bhargava; G K Aseri; Neelam Jain
Journal:  Appl Microbiol Biotechnol       Date:  2021-11-25       Impact factor: 4.813

5.  Perspectives of Phage Therapy in Non-bacterial Infections.

Authors:  Andrzej Górski; Paul L Bollyky; Maciej Przybylski; Jan Borysowski; Ryszard Międzybrodzki; Ewa Jończyk-Matysiak; Beata Weber-Dąbrowska
Journal:  Front Microbiol       Date:  2019-01-09       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.